Paper39768583
Diabetes Mellitus: A Risk Factor in Schlemm's Canal-Based Minimally Invasive Glaucoma Surgery.
Chihara E and 2 others. J Clin Med, 2024. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Diabetes Mellitus: A Risk Factor in Schlemm's Canal-Based Minimally Invasive Glaucoma Surgery. Papers, record 39768583. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39768583
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Diabetes Mellitus: A Risk Factor in Schlemm's Canal-Based Minimally Invasive Glaucoma Surgery.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References18
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26407657 | Microhook ab interno trabeculotomy, a novel minimally invasive glaucoma surgery, in eyes with open-angle glaucoma with scleral thinning. | Acta Ophthalmol | 2016 | https://conductscience.org/library/papers/26407657 | PubMed |
| 2 | 36457889 | Development and Application of a New T-shaped Internal Trabeculotomy Hook (T-hook). | Clin Ophthalmol | 2022 | https://conductscience.org/library/papers/36457889 | PubMed |
| 3 | 23355527 | Long-term outcomes of primary trabeculectomy in diabetic patients with primary open angle glaucoma. | Br J Ophthalmol | 2013 | https://conductscience.org/library/papers/23355527 | PubMed |
| 4 | 33315051 | A Small Molecule Inhibitor of VE-PTP Activates Tie2 in Schlemm's Canal Increasing Outflow Facility and Reducing Intraocular Pressure. | Invest Ophthalmol Vis Sci | 2020 | https://conductscience.org/library/papers/33315051 | PubMed |
| 5 | 24412282 | Gonioscopy-assisted transluminal trabeculotomy, ab interno trabeculotomy: technique report and preliminary results. | Ophthalmology | 2014 | https://conductscience.org/library/papers/24412282 | PubMed |
| 6 | 31863397 | Increased expression of periostin and tenascin-C in eyes with neovascular glaucoma secondary to PDR. | Graefes Arch Clin Exp Ophthalmol | 2020 | https://conductscience.org/library/papers/31863397 | PubMed |
| 7 | 21278588 | Selective laser trabeculoplasty in the treatment of open-angle glaucoma. | J Glaucoma | 2012 | https://conductscience.org/library/papers/21278588 | PubMed |
| 8 | 35439528 | Histological analysis of trabeculotomy - An investigation on the intraocular pressure lowering mechanism. | Exp Eye Res | 2022 | https://conductscience.org/library/papers/35439528 | PubMed |
| 9 | 12383805 | The Advanced Glaucoma Intervention Study (AGIS): 11. Risk factors for failure of trabeculectomy and argon laser trabeculoplasty. | Am J Ophthalmol | 2002 | https://conductscience.org/library/papers/12383805 | PubMed |
| 10 | 39201024 | Historical and Contemporary Debates in Schlemm's Canal-Based MIGS. | J Clin Med | 2024 | https://conductscience.org/library/papers/39201024 | PubMed |
| 11 | 34884242 | Comparison of Postoperative Hyphemas between Microhook Ab Interno Trabeculotomy and iStent Using a New Hyphema Scoring System. | J Clin Med | 2021 | https://conductscience.org/library/papers/34884242 | PubMed |
| 12 | 15882909 | Clinical results with the Trabectome for treatment of open-angle glaucoma. | Ophthalmology | 2005 | https://conductscience.org/library/papers/15882909 | PubMed |
| 13 | 36029305 | Risk factors of surgical failure in combined phacoemulsification and excisional goniotomy for angle-closure glaucoma. | Graefes Arch Clin Exp Ophthalmol | 2023 | https://conductscience.org/library/papers/36029305 | PubMed |
| 14 | 33031189 | Histologic Findings of Trabecular Meshwork and Schlemm's Canal After Microhook Ab Interno Trabeculotomy. | J Glaucoma | 2021 | https://conductscience.org/library/papers/33031189 | PubMed |
| 15 | 34526862 | Updates in Diabetic Wound Healing, Inflammation, and Scarring. | Semin Plast Surg | 2021 | https://conductscience.org/library/papers/34526862 | PubMed |
| 16 | 37430140 | Poly(l-Histidine)-Mediated On-Demand Therapeutic Delivery of Roughened Ceria Nanocages for Treatment of Chemical Eye Injury. | Adv Sci (Weinh) | 2023 | https://conductscience.org/library/papers/37430140 | PubMed |
| 17 | 23218696 | Preclinical investigation of ab interno trabeculectomy using a novel dual-blade device. | Am J Ophthalmol | 2013 | https://conductscience.org/library/papers/23218696 | PubMed |
| 18 | 38704819 | Consequences of Clot Formation and Hyphema Post-Internal Trabeculotomy for Glaucoma. | J Glaucoma | 2024 | https://conductscience.org/library/papers/38704819 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42642606 | Research Progress of Diabetes-related Glaucoma: Mechanisms, Impacts and Management Strategies. | Ophthalmic Physiol Opt | 2026 | https://conductscience.org/library/papers/42642606 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39768583
GET https://conductscience.org/api/papers/v1/39768583/authors